Richard Somberg

Richard Somberg

Company: Promega

Job title: Director, Pharma/Biotech Market Segment


Luminescence Technologies to Enable Discovery & Optimization of Effective Targeted Protein Degraders 10:30 am

A comprehensive suite of luminescence-based assays for degrader screening, characterization, and optimization Screening workflow considerations for PROTAC and molecular glue degraders Importance of cellular kinetics for optimizing degrader mechanism and efficacyRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.